A
Actinium Pharmaceuticals, IncATNM
Actinium is a pioneer in targeted radiotherapies designed to improve outcomes for patients with cancer. The company employs a biology-driven approach to develop differentiated radiopharmaceuticals for solid tumors and hematologic malignancies. Its mission is to transform cancer treatment through innovative radioconjugates that maximize therapeutic efficacy while minimizing toxicity to healthy tissue by combining expertise in tumor biology, translational medicine, and.
US StocksHealthcareSmall CapBiotechnology
ATNM の価格トレンド
Actinium Pharmaceuticals, Inc · TradingView フルチャート
NASDAQ:ATNM